Clinical Trial: The Study of Safety and Preliminary Efficacy of ALT001 in Patients with Mitochondrial Disease Due to m.3243A>G Mutation (China)

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The Study of Safety and Preliminary Efficacy of ALT001 in Patients with Mitochondrial Disease Due to m.3243A>G Mutation'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129595

Registration Time: 2026/08/06

Type: Interventional study

Primary Sponsor: Beijing Tiantan Hospital, Capital Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=317927

Published by HT Digital Content Services with permission from Health Daily Digest....